Mycronic AB
Sweden · SE0000375115 · reports in SEK · Europe
Four figures
From the annual report for the year to Dec 31, 2025. Each line says what it is based on.
- Revenue growth
- Revenue +12% in the year to Dec 31, 2025, on the year before.
- Return on equity
- It earned 22% on its shareholders' equity in the year to Dec 31, 2025.
- Equity and assets
- Equity is 65% of its assets, and operations brought in cash in the year.
- Price and earnings
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2025, consolidated, in SEK.
SEK 7.9B
revenue
24%
operating margin
SEK 1.6B
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | SEK 5.1B | SEK 5.7B | SEK 7.1B | SEK 7.9B |
| Operating profit | SEK 894M | SEK 1.2B | SEK 2.0B | SEK 1.9B |
| Net profit to shareholders | SEK 741M | SEK 998M | SEK 1.7B | SEK 1.6B |
| Dividend per share | SEK 3.50 | n/a | n/a | SEK 2.75 |
| Cash from operations | SEK 853M | SEK 1.6B | SEK 1.9B | SEK 1.4B |
| Capital spending | SEK 107M | SEK 103M | SEK 126M | SEK 91M |
| Cash | SEK 1.3B | SEK 2.1B | SEK 3.0B | SEK 2.3B |
| Total assets | SEK 7.3B | SEK 8.3B | SEK 10.4B | SEK 10.9B |
| Equity | SEK 4.7B | SEK 5.3B | SEK 6.6B | SEK 7.1B |
What they do
In the company's own words, from the annual report.
utveckling, tillverkning och försäljning av avancerad produktionsutrustning till elektronikindustrin.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the ratios from the filed figures.